VEEV Veeva Systems Inc.
Healthcare$158.54-1.02%ClosedMarket Cap: $25.87B
As of 2026-05-26
Valuation
P/E (TTM)
31.20
PEG
1.14
P/B
3.65
P/S
8.18
EV/EBITDA
25.95
DCF Value
$116.77
FCF Yield
5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.5%
Operating Margin
28.7%
Net Margin
28.4%
ROE
13.4%
ROA
10.1%
ROIC
9.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $836.0M | 74.5% | $245.9M | $244.2M | $— | — |
| FY null | $3.20B | 75.5% | $916.4M | $908.9M | $— | — |
| Q3 null | $811.2M | 75.4% | $240.9M | $236.2M | $— | — |
| Q2 null | $789.1M | 75.3% | $195.9M | $200.3M | $— | — |
| Q1 null | $759.0M | 77.1% | $233.7M | $228.2M | $— | — |
| Q4 null | $720.9M | 74.9% | $188.4M | $195.6M | $— | — |
| FY null | $2.75B | 74.5% | $691.4M | $714.1M | $— | — |
| Q3 null | $699.2M | 75.1% | $181.4M | $185.8M | $— | — |
| Q2 null | $676.2M | 74.8% | $166.5M | $171.0M | $— | — |
| Q1 null | $650.3M | 73.3% | $155.2M | $161.7M | $— | — |
| Q4 2024 | $630.6M | 72.4% | $135.3M | $147.4M | $0.90 | — |
| FY null | $2.36B | 71.3% | $429.3M | $525.7M | $— | — |